IMMvention retained rights to use its technology to potentially pursue other targets, such as Parkinson’s or Alzheimer’s ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

Palantir Technologies (NASDAQ:PLTR) has been described as the best pure-play stock in artificial intelligence. The market ...

Results from Novo Nordisk's STEP UP trial show that a high-dose formulation of Wegovy can significantly increase the weight ...

There are several major benefits of buying HGH and other medications through HGHmeds' online hormone clinic: ...

An international project into flu immunity could help develop better medications and vaccines to prevent severe disease.Imperial researchers will ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

The US plans to slash the price it pays for Novo Nordisk's Ozempic and Wegovy, the latest drugs to be targeted under legislation that's expected save the government more than $200 billion over a ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...